PMC:7212965 / 28016-29083
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T60 | 81-86 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
| T61 | 666-673 | Body_part | denotes | alanine | http://purl.org/sig/ont/fma/fma82749 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T45 | 81-86 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T115 | 638-646 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T116 | 819-827 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T117 | 983-991 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T118 | 1029-1037 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T218 | 33-35 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T219 | 81-86 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| T220 | 81-86 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
| T221 | 109-111 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
| T222 | 119-121 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
| T223 | 134-136 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T224 | 138-140 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
| T225 | 142-144 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
| T226 | 152-154 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
| T227 | 165-167 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
| T228 | 170-172 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
| T229 | 186-188 | http://purl.obolibrary.org/obo/CLO_0001407 | denotes | 52 |
| T230 | 237-239 | http://purl.obolibrary.org/obo/CLO_0054055 | denotes | 71 |
| T231 | 1059-1066 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T40 | 458-467 | Chemical | denotes | aspartate | http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314 |
| T43 | 482-485 | Chemical | denotes | AST | http://purl.obolibrary.org/obo/CHEBI_76649 |
| T44 | 666-673 | Chemical | denotes | alanine | http://purl.obolibrary.org/obo/CHEBI_16449 |
| T45 | 847-856 | Chemical | denotes | bilirubin | http://purl.obolibrary.org/obo/CHEBI_16990 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T119 | 81-100 | Phenotype | denotes | liver abnormalities | http://purl.obolibrary.org/obo/HP_0001392 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32407808-32171076-43469298 | 101-103 | 32171076 | denotes | 20 |
| 32407808-32257403-43469299 | 160-162 | 32257403 | denotes | 43 |
| 32407808-32241899-43469300 | 195-197 | 32241899 | denotes | 55 |
| 32407808-32213556-43469301 | 205-207 | 32213556 | denotes | 60 |
| 32407808-32217556-43469302 | 241-243 | 32217556 | denotes | 72 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T184 | 0-448 | Sentence | denotes | Based on our inclusion strategy, 34 of the 57 studies (60%) reported any data on liver abnormalities.20, 21, 22 , 25 , 27 , 28 , 30 , 34, 35, 36 , 38 , 41, 42, 43 , 45 , 48, 49, 50, 51, 52, 53 , 55 , 57 , 60 , 61 , 63 , 65, 66, 67 , 70, 71, 72 , 75 , 76 The majority of the studies that reported data on LFTs only reported continuous summary statistics (median and interquartile range) without reporting the number of patients with abnormal levels. |
| T185 | 449-656 | Sentence | denotes | Abnormal aspartate transaminase (AST), defined as any value above the upper limit of normal (ULN), was reported in 15.0% (95% CI, 13.6%– 16.5) of patients across 16 studies, including 2514 COVID-19 patients. |
| T186 | 657-837 | Sentence | denotes | Abnormal alanine transaminase (ALT), defined as any value above the ULN, was reported in 15.0% (95% CI, 13.6%–16.4%) of patients across 17 studies including 2711 COVID-19 patients. |
| T187 | 838-1001 | Sentence | denotes | Abnormal bilirubin, defined as any value above the ULN, was reported in 16.7% (95% CI, 15.0%–18.5%) of patients across 10 studies including 1841 COVID-19 patients. |
| T188 | 1002-1067 | Sentence | denotes | All patients had confirmed COVID-19 by laboratory RT-PCR testing. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 656 | 418-426 | Species | denotes | patients | Tax:9606 |
| 657 | 595-603 | Species | denotes | patients | Tax:9606 |
| 658 | 647-655 | Species | denotes | patients | Tax:9606 |
| 659 | 777-785 | Species | denotes | patients | Tax:9606 |
| 660 | 828-836 | Species | denotes | patients | Tax:9606 |
| 661 | 941-949 | Species | denotes | patients | Tax:9606 |
| 662 | 992-1000 | Species | denotes | patients | Tax:9606 |
| 663 | 1006-1014 | Species | denotes | patients | Tax:9606 |
| 664 | 847-856 | Chemical | denotes | bilirubin | MESH:D001663 |
| 665 | 81-100 | Disease | denotes | liver abnormalities | MESH:D008107 |
| 666 | 638-646 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 667 | 819-827 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 668 | 983-991 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 669 | 1029-1037 | Disease | denotes | COVID-19 | MESH:C000657245 |